1
|
Liu Y, Chen X, Liu XJ, Liu R, Hu HL, Min SX, Huang CH, Liu L, Tan GS. Five racemic phthalides from the aerial parts of Lycopodiastrum casuarinoides and their neuroprotective activities. PHYTOCHEMISTRY 2025; 233:114384. [PMID: 39756559 DOI: 10.1016/j.phytochem.2025.114384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2024] [Revised: 01/02/2025] [Accepted: 01/02/2025] [Indexed: 01/07/2025]
Abstract
Five racemic phthalides (1-5), including four undescribed phthalides monomers [(+)-1, (+)-2, (-)-2 and (-)-3], four undescribed phthalide dimers [(+)-4, (-)-4, (+)-5 and (-)-5], together with two known compounds [(-)-1 and (+)-3], were isolated from the aerial parts of Lycopodistrum casuarinoides. Their chemical structures were delineated by extensive spectroscopic data (UV, 1D/2D NMR, HRESIMS), in combination with the comparison of the experimental and calculated electronic circular dichroism spectra, calculated spin-spin coupling constants, and calculated NMR. All compounds were reported from Lycopodiaceae family for the first time. In addition, all isolates were tested for their neuroprotective effects on HT-22 cell injury induced by glutamate. Interestingly, among the five racemic phthalides, only the homologous dimers [(±)-5] displayed significant differences in neuroprotective effects, and (-)-5 exhibited the best neuroprotective activity against glutamate-induced HT-22 cells damage, with 29.3% increase rate in cell survival at 5 μM concentration. The neuroprotective effect of (-)-5 at different concentrations is equivalent to that of the positive control drug D/L-3-n-butylphthalide (racemic NBP). Furthermore, the biological evaluation revealed that (-)-5 could ameliorate glutamate-induced neuronal cell death via the Bax/Bcl-2 anti-apoptotic pathway.
Collapse
Affiliation(s)
- Yang Liu
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China; Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, Jiangxi, 341000, China; School of Pharmacy, Jiangxi Provincial Education Department Key Laboratory for the Application of Key Technologies in Drug Screening for Inflammatory Diseases and Phlegm Syndrome, Nanchang Medical College, Nanchang, Jiangxi, 330052, China; Jiangxi Provincial Key Laboratory of Tissue Engineering, 2024SSY06291, Gannan Medical University, Ganzhou, Jiangxi, 341000, China
| | - Xi Chen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China
| | - Xue-Jin Liu
- School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China
| | - Ren Liu
- School of Pharmacy, Jiangxi Provincial Education Department Key Laboratory for the Application of Key Technologies in Drug Screening for Inflammatory Diseases and Phlegm Syndrome, Nanchang Medical College, Nanchang, Jiangxi, 330052, China
| | - Hui-Ling Hu
- School of Pharmacy, Jiangxi Provincial Education Department Key Laboratory for the Application of Key Technologies in Drug Screening for Inflammatory Diseases and Phlegm Syndrome, Nanchang Medical College, Nanchang, Jiangxi, 330052, China
| | - Shan-Xue Min
- School of Pharmacy, Jiangxi Provincial Education Department Key Laboratory for the Application of Key Technologies in Drug Screening for Inflammatory Diseases and Phlegm Syndrome, Nanchang Medical College, Nanchang, Jiangxi, 330052, China
| | - Chao-Hui Huang
- School of Pharmacy, Jiangxi Provincial Education Department Key Laboratory for the Application of Key Technologies in Drug Screening for Inflammatory Diseases and Phlegm Syndrome, Nanchang Medical College, Nanchang, Jiangxi, 330052, China
| | - Lin Liu
- Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, Jiangxi, 341000, China; School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China; Jiangxi Provincial Key Laboratory of Tissue Engineering, 2024SSY06291, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.
| | - Gui-Shan Tan
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
| |
Collapse
|
2
|
Wen H, Li S, Wei Y, Sun Y, Fu L, Zhang X, Zhang Y. Bioassay and NMR-HSQC-Guided Isolation and Identification of Phthalide Dimers with Anti-Inflammatory Activity from the Rhizomes of Angelica sinensis. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2025; 73:4630-4641. [PMID: 39937046 DOI: 10.1021/acs.jafc.4c11704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/13/2025]
Abstract
Under the guidance of a bioactivity-guided approach and HSQC characteristic signals, nine pairs of phthalic dimers, angesilides A-I (1-9), with complex polycyclic skeletons featuring bridged, fused, and spiro ring systems were discovered from the rhizomes of Angelica sinensis. Their structures and absolute configurations were established by comprehensive spectroscopic methods, X-ray diffraction analysis, and chiral separation. Plausible biosynthetic pathway for 1-9 was proposed. Moreover, the anti-inflammatory activities of all isolates were evaluated in lipopolysaccharide (LPS) stimulated mouse leukemia cells of monocyte macrophages (RAW = 264.7). Among them, compound 9 showed a remarkable inhibitory activity with IC50 values of 425 nM and could significantly decrease IL-1β and IL-6 transcription levels. Interestingly, (+)-9 has superior NO inhibitory activity compared to that of (-)-9, which was verified by further molecular docking analysis. The findings provide new insights into A. sinensis as a functional food or for the development of new anti-inflammatory drug candidates.
Collapse
Affiliation(s)
- Hongyan Wen
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China
| | - Sheng Li
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China
| | - Yinling Wei
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China
| | - Yong Sun
- Beijing Academy of Food Sciences, Beijing 10068, China
| | - Lijun Fu
- Beijing Academy of Food Sciences, Beijing 10068, China
| | - Xiumin Zhang
- Beijing Academy of Food Sciences, Beijing 10068, China
| | - Yu Zhang
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China
| |
Collapse
|
3
|
Şenel P, Al Faysal A, Yilmaz Z, Erdoğan T, Odabaşoğlu M, Gölcü A. Investigation of the ability of 3-((4-chloro-6-methyl pyrimidin-2-yl)amino) isobenzofuran-1(3H)-one to bind to double-stranded deoxyribonucleic acid. Photochem Photobiol Sci 2024; 23:2107-2121. [PMID: 39522116 DOI: 10.1007/s43630-024-00655-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2024] [Accepted: 10/20/2024] [Indexed: 11/16/2024]
Abstract
Phthalides represent a notable category of secondary metabolites that are prevalent in various plant species, certain fungi, and liverworts. The significant pharmacological properties of these compounds have led to the synthesis of a novel phthalide derivative. The current study focuses on investigating the binding interactions of a newly synthesized 3-substituted phthalide derivative, specifically 3-((4-chloro-6-methyl pyrimidine-2-yl)amino) isobenzofuran-1(3H)-one (Z11), with double-stranded deoxyribonucleic acid (dsDNA). Research in the pharmaceutical and biological fields aimed at developing more potent DNA-binding agents must take into account the mechanisms by which these newly synthesized compounds interact with DNA. This investigation seeks to explore the binding dynamics between dsDNA and our compound through a variety of analytical techniques, such as electrochemistry, UV spectroscopy, fluorescence spectroscopy, and thermal denaturation. The binding constant (Kb) of Z11 with DNA was determined using both spectroscopic and voltammetric approaches. The research revealed that Z11 employs a groove binding mechanism to associate with dsDNA. To further explore the interactions between Z11 and dsDNA, the study utilized density functional theory (DFT) calculations, molecular docking, and molecular dynamics simulations. These analyses aimed to ascertain the potential for a stable complex formation between Z11 and dsDNA. The results indicate that Z11 is situated within the minor groove of the dsDNA, demonstrating the ability to establish a stable complex. Furthermore, the findings imply that both π-alkyl interactions and hydrogen bonding play significant roles in the stabilization of this complex.
Collapse
Affiliation(s)
- Pelin Şenel
- Faculty of Sciences and Letters, Department of Chemistry, Istanbul Technical University, Istanbul, 34469, Turkey
| | - Abdullah Al Faysal
- Faculty of Sciences and Letters, Department of Chemistry, Istanbul Technical University, Istanbul, 34469, Turkey
| | - Zeynep Yilmaz
- Faculty of Engineering, Chemical Engineering Department, Pamukkale University, Denizli, Turkey
| | - Taner Erdoğan
- Department of Chemistry and Chemical Processing Technologies, Kocaeli University, Kocaeli Vocational High School, Kocaeli, Turkey
| | - Mustafa Odabaşoğlu
- Chemistry Technology Programme, Pamukkale University, Kinikli, Denizli, 20070, Turkey
| | - Ayşegül Gölcü
- Faculty of Sciences and Letters, Department of Chemistry, Istanbul Technical University, Istanbul, 34469, Turkey.
| |
Collapse
|
4
|
Tan YZ, Yan HL, Liu YY, Yan YM, Wang L, Qiao JX, Wu J, Tian Y, Peng C. Structurally diverse phthalides from fibrous roots of Ligusticum chuanxiong Hort. and their biological activities. Fitoterapia 2024; 175:105882. [PMID: 38452906 DOI: 10.1016/j.fitote.2024.105882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Revised: 02/28/2024] [Accepted: 03/03/2024] [Indexed: 03/09/2024]
Abstract
Falonolide A (1) and B (2), two novel polyyne hybrid phthalides resulting from unprecedented carbon skeleton polymerized by Z-ligustilide and falcarindiol, along with six new related phthalides (3-8), were isolated from Ligusticum chuanxiong Hort. Their structures were elucidated by spectroscopic analysis, computer-assisted structure elucidation (CASE) analysis, DP4+ probability analysis and electronic circular dichroism (ECD) calculations. A plausible biosynthetic pathway for 1-8 was proposed, and the production mechanism of 2 was revealed by density functional theory (DFT) method. Compounds 4 and 6 exhibited significant vasodilatory activity with EC50 of 8.00 ± 0.86 and 6.92 ± 1.02 μM, respectively. Compound 4 also displayed significant inhibitory effect of NO production with EC50 value of 8.82 ± 0.30 μM. Based on the established compounds library, structure-activity relationship analysis of phthalides was explored to provide insights into the drug development of vasodilators and anti-flammatory.
Collapse
Affiliation(s)
- Yu-Zhu Tan
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China
| | - Hong-Ling Yan
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China
| | - Yun-Yun Liu
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China; Institute for Inheritance-Based Innovation of Chinese Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, PR China
| | - Yong-Ming Yan
- Institute for Inheritance-Based Innovation of Chinese Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, PR China
| | - Li Wang
- Shenzhen Branch, Guangdong Laboratory of Lingnan Modern Agriculture, Key Laboratory of Synthetic Biology, Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, Guangdong 518120, PR China
| | - Ji-Xu Qiao
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China
| | - Jing Wu
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China
| | - Yin Tian
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China.
| | - Cheng Peng
- Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China.
| |
Collapse
|
5
|
Zou J, Qiu ZC, Yu QQ, Wu JM, Wang YH, Shi KD, Li YF, He RR, Qin L, Yao XS, Wang XL, Gao H. Discovery of a Potent Antiosteoporotic Drug Molecular Scaffold Derived from Angelica sinensis and Its Bioinspired Total Synthesis. ACS CENTRAL SCIENCE 2024; 10:628-636. [PMID: 38559293 PMCID: PMC10979506 DOI: 10.1021/acscentsci.3c01414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/29/2024] [Accepted: 01/29/2024] [Indexed: 04/04/2024]
Abstract
Angelica sinensis, commonly known as Dong Quai in Europe and America and as Dang-gui in China, is a medicinal plant widely utilized for the prevention and treatment of osteoporosis. In this study, we report the discovery of a new category of phthalide from Angelica sinensis, namely falcarinphthalides A and B (1 and 2), which contains two fragments, (3R,8S)-falcarindiol (3) and (Z)-ligustilide (4). Falcarinphthalides A and B (1 and 2) represent two unprecedented carbon skeletons of phthalide in natural products, and their antiosteoporotic activities were evaluated. The structures of 1 and 2, including their absolute configurations, were established using extensive analysis of NMR spectra, chemical derivatization, and ECD/VCD calculations. Based on LC-HR-ESI-MS analysis and DFT calculations, a production mechanism for 1 and 2 involving enzyme-catalyzed Diels-Alder/retro-Diels-Alder reactions was proposed. Falcarinphthalide A (1), the most promising lead compound, exhibits potent in vitro antiosteoporotic activity by inhibiting NF-κB and c-Fos signaling-mediated osteoclastogenesis. Moreover, the bioinspired gram-scale total synthesis of 1, guided by intensive DFT study, has paved the way for further biological investigation. The discovery and gram-scale total synthesis of falcarinphthalide A (1) provide a compelling lead compound and a novel molecular scaffold for treating osteoporosis and other metabolic bone diseases.
Collapse
Affiliation(s)
- Jian Zou
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Zuo-Cheng Qiu
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
- Translational
Medicine R&D Center, Institute of Biomedical and Health Engineering/Key
Laboratory of Biomedical Imaging Science and System, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, People’s Republic of China
- College
of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Qiang-Qiang Yu
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Jia-Ming Wu
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Yong-Heng Wang
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Ke-Da Shi
- Translational
Medicine R&D Center, Institute of Biomedical and Health Engineering/Key
Laboratory of Biomedical Imaging Science and System, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, People’s Republic of China
| | - Yi-Fang Li
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Rong-Rong He
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Ling Qin
- Translational
Medicine R&D Center, Institute of Biomedical and Health Engineering/Key
Laboratory of Biomedical Imaging Science and System, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, People’s Republic of China
| | - Xin-Sheng Yao
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| | - Xin-Luan Wang
- Translational
Medicine R&D Center, Institute of Biomedical and Health Engineering/Key
Laboratory of Biomedical Imaging Science and System, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, People’s Republic of China
| | - Hao Gao
- Institute
of Traditional Chinese Medicine and Natural Products, College of Pharmacy/International
Cooperative Laboratory of Traditional Chinese Medicine Modernization
and Innovative Drug Development of Chinese Ministry of Education of
China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents
of TCM and New Drugs Research, Jinan University, Guangzhou 510632, People’s Republic of China
| |
Collapse
|
6
|
Huang L, Peng C, Guo L, Feng R, Shu HZ, Tian YC, Zhou QM, Xiong L. Six pairs of enantiomeric phthalide dimers from the rhizomes of Ligusticum chuanxiong and their absolute configurations and anti-inflammatory activities. Bioorg Chem 2022; 127:105970. [PMID: 35749854 DOI: 10.1016/j.bioorg.2022.105970] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Revised: 05/26/2022] [Accepted: 06/12/2022] [Indexed: 11/02/2022]
Abstract
Six pairs of enantiomeric phthalide dimers (1-6) were isolated from the rhizomes of Ligusticum chuanxiong. Their structures and absolute configurations were elucidated by NMR spectroscopy, X-ray diffraction analyses, and electronic circular dichroism calculations. Compounds (+)-1 and (-)-1 are new phthalide dimers, featuring two classes of monomeric units (a phthalide and an unusual 2,3-seco-phthalide) with an uncommon linkage (3,6'/8,3'a). Compounds (+)-2 and (-)-3 are also novel phthalide dimers that had not been reported previously. Although (-)-2 and (+)-3 have been successfully isolated in previous studies, their absolute configurations were not unambiguously determined. As for compound 4, it was reported as a racemate in one study, and one of its enantiomers was identified in a subsequent study. Herein, all enantiomeric phthalide dimers were successfully separated, and their absolute configurations were determined. The inhibitory effects of all isolates against lipopolysaccharide-induced nitric oxide production were tested using RAW264.7 cells. The results show that compounds (+)-2, (-)-2, (+)-3, (-)-3, (+)-4, (-)-4, (+)-5, (+)-6, and (-)-6 have inhibitory activities, with compound (+)-5 being the most active (IC50 value of 4.3 ± 1.3 μM).
Collapse
Affiliation(s)
- Lu Huang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Cheng Peng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| | - Li Guo
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Rui Feng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Hong-Zhen Shu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Yun-Cai Tian
- Shanghai Zhizhenzhichen Technologies Co. Ltd., Shanghai 201415, China
| | - Qin-Mei Zhou
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| | - Liang Xiong
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| |
Collapse
|
7
|
Wei X, Zeng Y, Sun C, Meng F, Wang Y. Recent advances in natural phthalides: Distribution, chemistry, and biological activities. Fitoterapia 2022; 160:105223. [PMID: 35654379 DOI: 10.1016/j.fitote.2022.105223] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Revised: 05/23/2022] [Accepted: 05/26/2022] [Indexed: 11/04/2022]
Abstract
Phthalides, an important class of bioactive natural products, are widely distributed in plants, fungi, lichens, and liverworts. Amon them, n-butylphthalide, a phthalide monomer, has been approved to cure ischemic stroke. Owing to their good bioactivities in anti-microbial, anti-inflammatory, anti-tumor, anti-diabetic, and other aspects, a large number of researches have been conducted on phthalides from nature materials. In recent years, hundreds of novel natural phthalides were obtained. This review provides profiles of the advances in the distribution, chemistry, and biological activities of natural phthalides in 2016-2022.
Collapse
Affiliation(s)
- Xiaodong Wei
- College of Bioengineering and Biotechnology, Tianshui Normal University, Tianshui 741001, PR China.
| | - Yanping Zeng
- College of Pharmaceutical Sciences, Key Laboratory of Luminescence Analysis and Molecular Sensing (Ministry of Education), Southwest University, Chongqing 400715, PR China
| | - Chao Sun
- Shandong Academy of Pharmaceutical Sciences, Ji'nan 250101, PR China
| | - Fancheng Meng
- College of Pharmaceutical Sciences, Key Laboratory of Luminescence Analysis and Molecular Sensing (Ministry of Education), Southwest University, Chongqing 400715, PR China
| | - Yibo Wang
- College of Bioengineering and Biotechnology, Tianshui Normal University, Tianshui 741001, PR China
| |
Collapse
|
8
|
Wang LY, Li WY, Zhou HF, Zhao XY, Li XN, Wu XD, Zhao QS. Spiroligustolides A and B: two pairs of enantiomeric spiro-orthoester-containing phthalide dimers as Cav3.1 calcium channel inhibitors from Ligusticum Chuanxiong Hort. Bioorg Chem 2022; 123:105749. [DOI: 10.1016/j.bioorg.2022.105749] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Revised: 02/21/2022] [Accepted: 03/17/2022] [Indexed: 12/27/2022]
|